Related Experiment Video
Updated: Aug 14, 2026
07:48
Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
[Informed consent, what information is left after a therapeutic trial?]
M Gallet1, J F Aupetit, E Servan
1Département de cardiologie, centre hospitalier St-Joseph et St-Luc, Lyon.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 1, 1994
Summary
Patients in a clinical trial recalled 60% of information from their consent forms. Key details like study aims and side effects were understood by only 40-50% of participants, highlighting a need for improved patient comprehension strategies.
Area of Science:
- Clinical Trials
- Patient Information & Consent
- Cardiology
Background:
- Informed consent is crucial for patient participation in clinical trials.
- Assessing patient recall of consent information is vital for ethical trial conduct.
- The IMPACT study investigated mexiletine for recent myocardial infarction.
Purpose of the Study:
- To evaluate patient recall and comprehension of information provided in a therapeutic trial consent form.
- To identify specific areas of consent information that are well-understood versus poorly understood by trial participants.
Main Methods:
- A questionnaire of 85 items was administered to 77 patients (68 men, 9 women; average age 57.9 years) from the IMPACT study.
- Patient recall of consent form details was assessed via 13 specific questions and a comprehension score (max 14 points).
- Recall was evaluated 5 to 21 months after trial completion.
Main Results:
- Patients recalled approximately 60% of the total information provided in the consent form.
- Recall varied significantly across different consent elements, with study aims, placebo, active treatment, randomization, and side effects understood by only 40-50% of patients.
- Information regarding trial centers, unblinding, and withdrawal rights was understood by 75-90% of patients.
- The global average comprehension score was 8.7 out of 14 points.
Conclusions:
- Patient recall of clinical trial consent information is incomplete and uneven.
- Critical elements of trial protocols, such as study objectives and potential risks, require enhanced communication strategies.
- Further research is needed to optimize patient understanding of informed consent documents in therapeutic trials.
Related Concept Videos
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:27Nursing Ethical Principles II
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
01:27Nurses' Legal Responsibilities I
In healthcare, informed consent is a crucial process that involves thoroughly communicating medical treatment options to patients, including benefits, risks, potential side effects, and alternatives. This process enables patients to make well-informed decisions about their care, ensuring they understand the implications of their choices before consenting to or refusing treatment.
The legal responsibilities of a nurse regarding informed consent include the following:
The legal responsibilities of a nurse regarding informed consent include the following:
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...